Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
Posted On Friday, August 08, 2025
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 08, 2025
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
Posted On Friday, August 08, 2025
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 08, 2025
Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights
Posted On Friday, August 08, 2025
Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Friday, August 08, 2025
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Posted On Friday, August 08, 2025
Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025
Posted On Friday, August 08, 2025
NurExone’s Exosomes Show Stronger Healing Potential Than Industry Standard
Posted On Friday, August 08, 2025
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 08, 2025
Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
Posted On Friday, August 08, 2025
Capricor Therapeutics Announces Type A Meeting Scheduled with U.S. FDA
Posted On Friday, August 08, 2025
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
Posted On Friday, August 08, 2025
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Posted On Friday, August 08, 2025
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
Posted On Friday, August 08, 2025
FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
Posted On Friday, August 08, 2025
Vaxart CEO Issues Letter to Stockholders
Posted On Friday, August 08, 2025
Spectral Medical Announces Second Quarter and Provides Corporate Update
Posted On Friday, August 08, 2025
Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Friday, August 08, 2025
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
Posted On Friday, August 08, 2025
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance
Posted On Friday, August 08, 2025
Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
Posted On Friday, August 08, 2025
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
Posted On Friday, August 08, 2025
Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
Posted On Thursday, August 07, 2025
Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights
Posted On Thursday, August 07, 2025

1
2
3
4
5
6
7
8
9
…
Next page
Last page

Print